THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $477,939 | -19.3% | 55,381 | -3.2% | 0.00% | – |
| Q2 2023 | $591,979 | -3.9% | 57,196 | +0.7% | 0.00% | – |
| Q1 2023 | $616,227 | -0.8% | 56,795 | +2.5% | 0.00% | – |
| Q4 2022 | $621,486 | +9.8% | 55,391 | -0.8% | 0.00% | – |
| Q3 2022 | $566,000 | +6.0% | 55,859 | -5.2% | 0.00% | – |
| Q2 2022 | $534,000 | -2.7% | 58,904 | +2.6% | 0.00% | – |
| Q1 2022 | $549,000 | -13.4% | 57,388 | -0.0% | 0.00% | – |
| Q4 2021 | $634,000 | +100.6% | 57,397 | +34.3% | 0.00% | – |
| Q3 2021 | $316,000 | -31.0% | 42,749 | +35.6% | 0.00% | – |
| Q2 2021 | $458,000 | -27.8% | 31,525 | +1.5% | 0.00% | – |
| Q1 2021 | $634,000 | +14.2% | 31,064 | -0.6% | 0.00% | – |
| Q4 2020 | $555,000 | +19.9% | 31,265 | 0.0% | 0.00% | – |
| Q3 2020 | $463,000 | -34.1% | 31,265 | -6.7% | 0.00% | – |
| Q2 2020 | $703,000 | -10.4% | 33,495 | -1.5% | 0.00% | – |
| Q1 2020 | $785,000 | +21.5% | 33,988 | +36.3% | 0.00% | – |
| Q4 2019 | $646,000 | +42.9% | 24,940 | +7.6% | 0.00% | – |
| Q3 2019 | $452,000 | +33.3% | 23,178 | +11.5% | 0.00% | – |
| Q2 2019 | $339,000 | -26.3% | 20,790 | +2.5% | 0.00% | – |
| Q1 2019 | $460,000 | -6.5% | 20,290 | +5.4% | 0.00% | – |
| Q4 2018 | $492,000 | +9.6% | 19,244 | +40.0% | 0.00% | – |
| Q3 2018 | $449,000 | +43.9% | 13,742 | 0.0% | 0.00% | – |
| Q2 2018 | $312,000 | -13.6% | 13,742 | -7.7% | 0.00% | – |
| Q1 2018 | $361,000 | -38.9% | 14,881 | -29.6% | 0.00% | – |
| Q4 2017 | $591,000 | -8.5% | 21,140 | +12.2% | 0.00% | – |
| Q3 2017 | $646,000 | -0.5% | 18,840 | +15.7% | 0.00% | -100.0% |
| Q2 2017 | $649,000 | +12.7% | 16,289 | +3.7% | 0.00% | – |
| Q1 2017 | $576,000 | +28.6% | 15,713 | +11.6% | 0.00% | – |
| Q4 2016 | $448,000 | – | 14,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
| Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
| Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
| Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
| Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
| CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
| Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
| King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
| Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
| PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |